Fate Therapeutics Financial Overview
Fate Therapeutics's market cap is currently $115.35M. The company's EPS TTM is $-0.27; its P/E ratio is -0.76; Fate Therapeutics is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.27. See an overview of income statement, balance sheet, and cash flow financials.
